Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-capital ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 387,881 | 348,548 | 375,294 | 333,661 | 300,421 | 270,041 | 241,092 | 220,221 | 206,831 | 198,661 | 188,944 | 178,651 | 169,598 | 156,628 | 111,201 | 99,676 | 87,630 | 77,983 | 63,282 | 51,176 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $387,881K)
= 0.00
The debt-to-capital ratio of Catalyst Pharmaceuticals Inc has consistently remained at 0.00 over the past several periods. This indicates that the company has not utilized debt as a significant source of financing relative to its total capital structure. A debt-to-capital ratio of 0.00 implies that the company's capital structure is predominantly equity-financed, which may indicate a lower risk profile compared to companies with higher debt levels. It suggests that Catalyst Pharmaceuticals has been able to operate and grow without relying heavily on external debt funding, potentially reducing its interest expenses and financial risks associated with debt.
Peer comparison
Dec 31, 2023